Global Argatroban Market Insights, Forecast to 2025

Publisher Name :
Date: 25-Feb-2019
No. of pages: 117
Inquire Before Buying

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

In the last several years, global market of Argatroban Industry decreased with the average production growth rate about -15%. In 2015, global capacity of Argatroban reduced to 34786 grams

from 65183 grams since 2011. It is predicted that the argatroban demand will continue to decrease with a average growth rate of -9% in the coming five years.

Japan is the still largest supplier of argatroban with the production market share of 35% and the consumption market share of 22% in 2015.

The price of argatroban is relatively expensive. The largest consumers are developed countries with high income. USA occupied a market share of 34%. The second place is Europe, following North America with the consumption market share of 22% in 2015.

China has few companies entering the market with production share of only 8%, and demand cannot be satisfied with supply. Large quantities of argatroban have to be imported.

Intially, compared with hirudin and heparin, the therapeutic dose has little effect on platelet, no antigen and strong antithrombotic effect. The sale value has reached 190 million USA dollars in 2008. But because of its narrow therapeutic area, uncertain factors on human's bodies and fierce competition from other substitutes, it sales far less than other thrombin inhibitor. The value reduced to 101 million USA dollars in 2015.

The global Argatroban market is valued at 84 million US$ in 2018 and will reach 23 million US$ by the end of 2025, growing at a CAGR of -15.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Argatroban market based on company, product type, end user and key regions.

This report studies the global market size of Argatroban in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Argatroban in these regions.

This research report categorizes the global Argatroban market by top players/brands, region, type and end user. This report also studies the global Argatroban market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Pfizer, Inc

- SANDOZ

- GlaxoSmithKline Plc

- fresenius-kabi

- Eagle Pharmaceuticals, Inc

- Mitsubishi Tanabe Pharma

- Teva Pharmaceutical Industries Ltd

- WEST-WARD,INC

Market size by Product

- Argatroban Powder

- Argatroban Injection

Market size by End User

- Heparin-induced thrombocytopenia (HIT)

- Percutaneous Coronary Intervention

- Cerebral arterial thrombosis

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Argatroban market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Argatroban market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Argatroban companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Argatroban submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Argatroban are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (g). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Argatroban market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Argatroban Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Argatroban Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Argatroban Market Size Growth Rate by Product
1.4.2 Argatroban Powder
1.4.3 Argatroban Injection
1.5 Market by End User
1.5.1 Global Argatroban Market Size Growth Rate by End User
1.5.2 Heparin-induced thrombocytopenia (HIT)
1.5.3 Percutaneous Coronary Intervention
1.5.4 Cerebral arterial thrombosis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Argatroban Market Size
2.1.1 Global Argatroban Revenue 2014-2025
2.1.2 Global Argatroban Sales 2014-2025
2.2 Argatroban Growth Rate by Regions
2.2.1 Global Argatroban Sales by Regions
2.2.2 Global Argatroban Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Argatroban Sales by Manufacturers
3.1.1 Argatroban Sales by Manufacturers
3.1.2 Argatroban Sales Market Share by Manufacturers
3.1.3 Global Argatroban Market Concentration Ratio (CR5 and HHI)
3.2 Argatroban Revenue by Manufacturers
3.2.1 Argatroban Revenue by Manufacturers (2014-2019)
3.2.2 Argatroban Revenue Share by Manufacturers (2014-2019)
3.3 Argatroban Price by Manufacturers
3.4 Argatroban Manufacturing Base Distribution, Product Types
3.4.1 Argatroban Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Argatroban Product Type
3.4.3 Date of International Manufacturers Enter into Argatroban Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Argatroban Sales by Product
4.2 Global Argatroban Revenue by Product
4.3 Argatroban Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Argatroban Breakdown Data by End User
6 North America
6.1 North America Argatroban by Countries
6.1.1 North America Argatroban Sales by Countries
6.1.2 North America Argatroban Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Argatroban by Product
6.3 North America Argatroban by End User
7 Europe
7.1 Europe Argatroban by Countries
7.1.1 Europe Argatroban Sales by Countries
7.1.2 Europe Argatroban Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Argatroban by Product
7.3 Europe Argatroban by End User
8 Asia Pacific
8.1 Asia Pacific Argatroban by Countries
8.1.1 Asia Pacific Argatroban Sales by Countries
8.1.2 Asia Pacific Argatroban Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Argatroban by Product
8.3 Asia Pacific Argatroban by End User
9 Central & South America
9.1 Central & South America Argatroban by Countries
9.1.1 Central & South America Argatroban Sales by Countries
9.1.2 Central & South America Argatroban Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Argatroban by Product
9.3 Central & South America Argatroban by End User
10 Middle East and Africa
10.1 Middle East and Africa Argatroban by Countries
10.1.1 Middle East and Africa Argatroban Sales by Countries
10.1.2 Middle East and Africa Argatroban Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Argatroban by Product
10.3 Middle East and Africa Argatroban by End User
11 Company Profiles
11.1 Pfizer, Inc
11.1.1 Pfizer, Inc Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer, Inc Argatroban Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer, Inc Argatroban Products Offered
11.1.5 Pfizer, Inc Recent Development
11.2 SANDOZ
11.2.1 SANDOZ Company Details
11.2.2 Company Business Overview
11.2.3 SANDOZ Argatroban Sales, Revenue and Gross Margin (2014-2019)
11.2.4 SANDOZ Argatroban Products Offered
11.2.5 SANDOZ Recent Development
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Company Details
11.3.2 Company Business Overview
11.3.3 GlaxoSmithKline Plc Argatroban Sales, Revenue and Gross Margin (2014-2019)
11.3.4 GlaxoSmithKline Plc Argatroban Products Offered
11.3.5 GlaxoSmithKline Plc Recent Development
11.4 fresenius-kabi
11.4.1 fresenius-kabi Company Details
11.4.2 Company Business Overview
11.4.3 fresenius-kabi Argatroban Sales, Revenue and Gross Margin (2014-2019)
11.4.4 fresenius-kabi Argatroban Products Offered
11.4.5 fresenius-kabi Recent Development
11.5 Eagle Pharmaceuticals, Inc
11.5.1 Eagle Pharmaceuticals, Inc Company Details
11.5.2 Company Business Overview
11.5.3 Eagle Pharmaceuticals, Inc Argatroban Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Eagle Pharmaceuticals, Inc Argatroban Products Offered
11.5.5 Eagle Pharmaceuticals, Inc Recent Development
11.6 Mitsubishi Tanabe Pharma
11.6.1 Mitsubishi Tanabe Pharma Company Details
11.6.2 Company Business Overview
11.6.3 Mitsubishi Tanabe Pharma Argatroban Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Mitsubishi Tanabe Pharma Argatroban Products Offered
11.6.5 Mitsubishi Tanabe Pharma Recent Development
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Teva Pharmaceutical Industries Ltd Company Details
11.7.2 Company Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd Argatroban Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Teva Pharmaceutical Industries Ltd Argatroban Products Offered
11.7.5 Teva Pharmaceutical Industries Ltd Recent Development
11.8 WEST-WARD,INC
11.8.1 WEST-WARD,INC Company Details
11.8.2 Company Business Overview
11.8.3 WEST-WARD,INC Argatroban Sales, Revenue and Gross Margin (2014-2019)
11.8.4 WEST-WARD,INC Argatroban Products Offered
11.8.5 WEST-WARD,INC Recent Development
12 Future Forecast
12.1 Argatroban Market Forecast by Regions
12.1.1 Global Argatroban Sales Forecast by Regions 2019-2025
12.1.2 Global Argatroban Revenue Forecast by Regions 2019-2025
12.2 Argatroban Market Forecast by Product
12.2.1 Global Argatroban Sales Forecast by Product 2019-2025
12.2.2 Global Argatroban Revenue Forecast by Product 2019-2025
12.3 Argatroban Market Forecast by End User
12.4 North America Argatroban Forecast
12.5 Europe Argatroban Forecast
12.6 Asia Pacific Argatroban Forecast
12.7 Central & South America Argatroban Forecast
12.8 Middle East and Africa Argatroban Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Argatroban Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Argatroban Product Picture
Table Argatroban Market Segments
Table Key Manufacturers Argatroban Covered
Table Global Argatroban Market Size Growth Rate by Product 2019-2025 (g) & (Million US$)
Figure Global Argatroban Sales Market Share by Product 2014-2025
Figure Argatroban Powder Product Picture
Table Major Manufacturers of Argatroban Powder
Figure Argatroban Injection Product Picture
Table Major Manufacturers of Argatroban Injection
Table Global Argatroban Market Size Growth Rate by End User 2019-2025 (g)
Figure Heparin-induced thrombocytopenia (HIT)
Figure Percutaneous Coronary Intervention
Figure Cerebral arterial thrombosis
Figure Argatroban Report Years Considered
Figure Global Argatroban Market Size 2014-2025 (Million US$)
Figure Global Argatroban Sales 2014-2025 (g)
Table Global Argatroban Market Size by Regions 2014-2019 (g) & (Million US$)
Table Global Argatroban Sales by Regions 2014-2019 (g)
Table Global Argatroban Sales Market Share by Regions 2014-2019
Figure Global Argatroban Sales Market Share by Regions 2014-2019
Figure 2018 Global Argatroban Sales Market Share by Regions
Table Global Argatroban Revenue by Regions 2014-2019 (Million US$)
Table Global Argatroban Revenue Market Share by Regions 2014-2019
Figure Global Argatroban Revenue Market Share by Regions 2014-2019
Figure 2018 Global Argatroban Revenue Market Share by Regions
Table Global Argatroban Sales by Manufacturers (2014-2019) (g)
Table Global Argatroban Sales Share by Manufacturers (2014-2019)
Figure Global Argatroban Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Argatroban Revenue by Manufacturers (2014-2019) (Million USD)
Table Argatroban Revenue Share by Manufacturers (2014-2019)
Figure Argatroban Value Share by Manufacturers in 2018
Table Key Manufacturers Argatroban Price (2014-2019) (USD/g)
Table Argatroban Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Argatroban Product Type
Table Date of International Manufacturers Enter into Argatroban Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Argatroban Sales by Product (2014-2019) (g)
Table Global Argatroban Sales Share by Product (2014-2019)
Figure Global Argatroban Sales Market Share by Product (2014-2019)
Figure Global Argatroban Sales Market Share by Product in 2018
Table Global Argatroban Revenue by Product (2014-2019) (Million US$)
Table Global Argatroban Revenue Share by Product (2014-2019)
Figure Global Argatroban Revenue Market Share by Product (2014-2019)
Figure Global Argatroban Revenue Market Share by Product in 2018
Table Argatroban Price by Product 2014-2019 (USD/g)
Table Global Argatroban Sales by End User (2014-2019) (g)
Table Global Argatroban Sales Share by End User (2014-2019)
Figure Global Sales Argatroban Market Share by End User (2014-2019)
Figure Global Sales Argatroban Market Share by End User in 2018
Figure North America Argatroban Sales Growth Rate 2014-2019 (g)
Figure North America Argatroban Revenue Growth Rate 2014-2019 (Million US$)
Table North America Argatroban Sales by Countries (2014-2019) (g)
Table North America Argatroban Sales Market Share by Countries (2014-2019)
Figure 2018 North America Argatroban Sales Market Share by Countries
Table North America Argatroban Revenue by Countries (2014-2019) (Million US$)
Table North America Argatroban Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Argatroban Revenue Market Share by Countries
Figure United States Argatroban Sales Growth Rate (2014-2019) (g)
Figure United States Argatroban Revenue Growth Rate (2014-2019) (g)
Figure Canada Argatroban Sales Growth Rate (2014-2019) (g)
Figure Canada Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Argatroban Sales Growth Rate (2014-2019) (g)
Figure Mexico Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Table North America Argatroban Sales by Product (2014-2019) (g)
Table North America Argatroban Sales Market Share by Product (2014-2019)
Figure 2018 North America Argatroban Market Share by Product
Table North America Argatroban Sales by End User (2014-2019) (g)
Table North America Argatroban Sales Market Share by End User (2014-2019)
Figure 2018 North America Argatroban Market Share by End User
Figure Europe Argatroban Sales Growth Rate 2014-2019 (g)
Figure Europe Argatroban Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Argatroban Sales by Countries (2014-2019) (g)
Table Europe Argatroban Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Argatroban Sales Market Share by Countries
Table Europe Argatroban Revenue by Countries (2014-2019) (Million US$)
Table Europe Argatroban Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Argatroban Revenue Market Share by Countries
Figure Germany Argatroban Sales Growth Rate (2014-2019) (g)
Figure Germany Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure France Argatroban Sales Growth Rate (2014-2019) (g)
Figure France Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Argatroban Sales Growth Rate (2014-2019) (g)
Figure UK Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Argatroban Sales Growth Rate (2014-2019) (g)
Figure Italy Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Argatroban Sales Growth Rate (2014-2019) (g)
Figure Russia Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Argatroban Sales by Product (2014-2019) (g)
Table Europe Argatroban Sales Market Share by Product (2014-2019)
Figure 2018 Europe Argatroban Market Share by Product
Table Europe Argatroban Sales by End User (2014-2019) (g)
Table Europe Argatroban Sales Market Share by End User (2014-2019)
Figure 2018 Europe Argatroban Market Share by End User
Figure Asia Pacific Argatroban Sales Growth Rate 2014-2019 (g)
Figure Asia Pacific Argatroban Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Argatroban Sales by Countries (2014-2019) (g)
Table Asia Pacific Argatroban Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Argatroban Sales Market Share by Countries
Table Asia Pacific Argatroban Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Argatroban Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Argatroban Revenue Market Share by Countries
Figure China Argatroban Sales Growth Rate (2014-2019) (g)
Figure China Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Argatroban Sales Growth Rate (2014-2019) (g)
Figure Japan Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Argatroban Sales Growth Rate (2014-2019) (g)
Figure Korea Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure India Argatroban Sales Growth Rate (2014-2019) (g)
Figure India Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Argatroban Sales Growth Rate (2014-2019) (g)
Figure Australia Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Argatroban Sales Growth Rate (2014-2019) (g)
Figure Indonesia Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Argatroban Sales Growth Rate (2014-2019) (g)
Figure Malaysia Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Argatroban Sales Growth Rate (2014-2019) (g)
Figure Philippines Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Argatroban Sales Growth Rate (2014-2019) (g)
Figure Thailand Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Argatroban Sales Growth Rate (2014-2019) (g)
Figure Vietnam Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Argatroban Sales Growth Rate (2014-2019) (g)
Figure Singapore Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Argatroban Sales by Product (2014-2019) (g)
Table Asia Pacific Argatroban Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Argatroban Market Share by Product
Table Asia Pacific Argatroban Sales by End User (2014-2019) (g)
Table Asia Pacific Argatroban Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Argatroban Market Share by End User
Figure Central & South America Argatroban Sales Growth Rate 2014-2019 (g)
Figure Central & South America Argatroban Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Argatroban Sales by Countries (2014-2019) (g)
Table Central & South America Argatroban Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Argatroban Sales Market Share by Countries
Table Central & South America Argatroban Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Argatroban Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Argatroban Revenue Market Share by Countries
Figure Brazil Argatroban Sales Growth Rate (2014-2019) (g)
Figure Brazil Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Argatroban Sales Growth Rate (2014-2019) (g)
Figure Argentina Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Argatroban Sales by Product (2014-2019) (g)
Table Central & South America Argatroban Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Argatroban Market Share by Product
Table Central & South America Argatroban Sales by End User (2014-2019) (g)
Table Central & South America Argatroban Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Argatroban Market Share by End User
Figure Middle East and Africa Argatroban Sales Growth Rate 2014-2019 (g)
Figure Middle East and Africa Argatroban Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Argatroban Sales by Countries (2014-2019) (g)
Table Middle East and Africa Argatroban Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Argatroban Sales Market Share by Countries
Table Middle East and Africa Argatroban Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Argatroban Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Argatroban Revenue Market Share by Countries
Figure GCC Countries Argatroban Sales Growth Rate (2014-2019) (g)
Figure GCC Countries Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Argatroban Sales Growth Rate (2014-2019) (g)
Figure Turkey Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Argatroban Sales Growth Rate (2014-2019) (g)
Figure Egypt Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Argatroban Sales Growth Rate (2014-2019) (g)
Figure South Africa Argatroban Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Argatroban Sales by Product (2014-2019) (g)
Table Middle East and Africa Argatroban Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Argatroban Market Share by Product
Table Middle East and Africa Argatroban Sales by End User (2014-2019) (g)
Table Middle East and Africa Argatroban Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Argatroban Market Share by End User
Table Pfizer, Inc Company Details
Table Pfizer, Inc Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table Pfizer, Inc Recent Development
Table SANDOZ Company Details
Table SANDOZ Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table SANDOZ Recent Development
Table GlaxoSmithKline Plc Company Details
Table GlaxoSmithKline Plc Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Recent Development
Table fresenius-kabi Company Details
Table fresenius-kabi Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table fresenius-kabi Recent Development
Table Eagle Pharmaceuticals, Inc Company Details
Table Eagle Pharmaceuticals, Inc Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table Eagle Pharmaceuticals, Inc Recent Development
Table Mitsubishi Tanabe Pharma Company Details
Table Mitsubishi Tanabe Pharma Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table Mitsubishi Tanabe Pharma Recent Development
Table Teva Pharmaceutical Industries Ltd Company Details
Table Teva Pharmaceutical Industries Ltd Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Ltd Recent Development
Table WEST-WARD,INC Company Details
Table WEST-WARD,INC Argatroban Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table WEST-WARD,INC Recent Development
Table Global Argatroban Sales Forecast by Regions 2019-2025 (g)
Table Global Argatroban Sales Market Share Forecast by Regions 2019-2025
Table Global Argatroban Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Argatroban Revenue Market Share Forecast by Regions 2019-2025
Table Global Argatroban Sales Forecast by Product 2019-2025 (g)
Table Global Argatroban Sales Market Share Forecast by Product 2019-2025
Table Global Argatroban Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Argatroban Revenue Market Share Forecast by Product 2019-2025
Table Global Argatroban Sales Forecast by End User 2019-2025 (g)
Table Global Argatroban Sales Market Share Forecast by End User 2019-2025
Figure North America Argatroban Sales Growth Rate Forecast (2019-2025) (g)
Figure North America Argatroban Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Argatroban Sales Growth Rate Forecast (2019-2025) (g)
Figure Europe Argatroban Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Argatroban Sales Growth Rate Forecast (2019-2025) (g)
Figure Asia Pacific Argatroban Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Argatroban Sales Growth Rate Forecast (2019-2025) (g)
Figure Central & South America Argatroban Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Argatroban Sales Growth Rate Forecast (2019-2025) (g)
Figure Middle East and Africa Argatroban Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Argatroban Value Chain
Table Argatroban Customers List
Table Argatroban Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Penicillin and Streptomycin Market Professional Survey Report 2019
    Published: 20-Nov-2019        Price: US 3500 Onwards        Pages: 114
    The global Penicillin and Streptomycin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Penicillin and Streptomycin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Penicillin and Streptomycin market size by analyzing historical data and future prospect. Regionally, this report categorizes the produ......
  • Global Histone Deacetylase (HDAC) Inhibitors Market Professional Survey Report 2019
    Published: 20-Nov-2019        Price: US 3500 Onwards        Pages: 114
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Histone Deacetylase (HDAC) Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Histone Deacetylase (HDAC) Inhibitors market size by analyzing historical data and future prospect. Regionally, thi......
  • Global Atropine Market Growth 2019-2024
    Published: 20-Nov-2019        Price: US 3660 Onwards        Pages: 163
    According to this study, over the next five years the Atropine market will register a -1.8% CAGR in terms of revenue, the global market size will reach US$ 492.2 million by 2024, from US$ 528.5 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Atropine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Atropine market by product type, application......
  • Global Epinephrine Market Growth 2019-2024
    Published: 20-Nov-2019        Price: US 3660 Onwards        Pages: 163
    According to this study, over the next five years the Epinephrine market will register a 7.4% CAGR in terms of revenue, the global market size will reach US$ 3131.7 million by 2024, from US$ 2354.1 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Epinephrine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Epinephrine market by product type, a......
  • Global Zika Virus Testing Market Study 2016-2026, by Segment (Molecular Test, Serologic Test) , by Market (Diagnostic Centers, Hospitals,) , by Company (Latin America, North Amercia,)
    Published: 19-Nov-2019        Price: US 1800 Onwards        Pages: 57
    Summary Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don't get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people mi......
  • Global Vincamine Market Study 2016-2026, by Segment (Vincamine Tablets, Vincamine Capsules) , by Market (Vincamine 10 mg, Vincamine 30 Mg) , by Company (Biofarm, Rompharm Company,)
    Published: 19-Nov-2019        Price: US 1800 Onwards        Pages: 47
    Summary Vincamine is a natural nootropic supplement which is found in the Periwinkle plant (Vinca Minor). It was first extracted in industrial quantities by a team of scientists examining compounds that had vasoactive properties in 1955. The global Vincamine market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Vincamine Tablets......
  • Global Urokinase Market Study 2016-2026, by Segment (Urokinase Powder, Urokinase Solution) , by Market (Hospital, Clinic,) , by Company (Wanhua Biochem, NDPharm,)
    Published: 19-Nov-2019        Price: US 1800 Onwards        Pages: 56
    Summary Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine pro......
  • Global Thin Film Drugs Market Study 2016-2026, by Segment (Transdermal Film, Oral Thin Film,) , by Market (Hospitals, Drugstores,) , by Company (LTS, GSK,)
    Published: 19-Nov-2019        Price: US 1800 Onwards        Pages: 64
    Summary Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made. The global Thin Film Drugs market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.......
  • Global Thin Film Drug Market Study 2016-2026, by Segment (Transdermal Film, Oral Thin Film,) , by Market (Hospitals, Drugstores,) , by Company (GSK, LTS,)
    Published: 19-Nov-2019        Price: US 1800 Onwards        Pages: 67
    Summary Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made. The global Thin Film Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs